… of NK cells in patients with moderate and severe COVID-19 … with moderate and severe
COVID-19 disease were recruited … NK cell activation, education, and presence of adaptive NK cells…

… cells (CD57 + ), and an increased CD56 DIM :CD56 BRIGHT ratio. The increase in CD56
DIM cells may be compensatory to the loss of natural killer cell … in our fight against COVID-19. …

… to NK cells in COVID-19. We discuss the impacts of COVID-19 on host NK cell phenotype
and … and hypofunctional profile of these cells. We enumerate the changes induced in infected …

… coronavirus disease 2019 (COVID-19) [3]. In this Review, current knowledge of antiviral
responses of natural killer (NK) cells and unconventional T cells … on the role of these cells in the …

… between NK cell activation, T cell … cells in patients with moderate and severe COVID-19
disease. With strict inclusion and exclusion criteria, patients with moderate and severe COVID-19 …

… 19, to enhance NK cell-mediated viral clearance. We therefore analyzed whether NK cells
from COVID-19 … We found that NK cells isolated from the blood of ARDS COVID-19 patients …

… Our findings suggest that impaired counts and cytolytic activity of NK cells are important
characteristics of severe COVID-19 and can potentially facilitate strategies for …

… cells that fight against infected cells. The function of these cells is impaired in patients with
COVID-19 … the disease or destroy the infected cells. Few studies have evaluated the effects of …

… COVID-19 patients with severe pneumonia [19]. While there is limited data available on the
role of NK cells in COVID-19 … exhaustion of NK cells and T cells could further complicate the …

… cells respond in both early and late coronavirus infections, and the implication for ongoing
COVID-19 … recommendations for therapeutic strategies against COVID-19 in clearing the virus …